Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Chimeric Therapeutics Ltd. has announced the cessation of 5,816,912 securities due to the lapse of conditional rights. The conditions for these securities were not met, leading to their expiration on December 20, 2024. This development might influence investor perspectives on the company’s stock performance.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.